Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauren K Jillson

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cancers|July 2, 2021
Androgen Receptor Signaling in Prostate Cancer Genomic SubtypesLauren K Jillson, Gabriel A Yette, Teemu D Laajala, et al.
Molecular Cancer Research : MCR|July 14, 2019
Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous RecombinationSatoshi Washino, Leah C Rider, Lina Romero, et al.
Molecular Cancer Research : MCR|April 13, 2021
<i>MAP3K7</i> Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of <i>CHD1</i>Lauren K Jillson, Leah C Rider, Lindsey U Rodrigues, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cancers|July 2, 2021
Androgen Receptor Signaling in Prostate Cancer Genomic SubtypesLauren K Jillson, Gabriel A Yette, Teemu D Laajala, et al.
Molecular Cancer Research : MCR|July 14, 2019
Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous RecombinationSatoshi Washino, Leah C Rider, Lina Romero, et al.
Molecular Cancer Research : MCR|April 13, 2021
<i>MAP3K7</i> Loss Drives Enhanced Androgen Signaling and Independently Confers Risk of Recurrence in Prostate Cancer with Joint Loss of <i>CHD1</i>Lauren K Jillson, Leah C Rider, Lindsey U Rodrigues, et al.
Pageof 1